Midlands Engine Investment Fund
Steel City House, West Street, Sheffield, S1 2GQ, United Kingdom
Overview
MEIF is an investment firm that operates equity and debt investment towards growth capital. The firm aims to transform the finance landscape for smaller businesses in the Midlands and to realize the region’s potential to achieve economic growth through enterprise. It is a collaboration between the British Business Bank and ten Local Enterprise Partnerships (LEPs) in the West Midlands and East and South East Midlands. MEIF provides over £250m of investment to boost small and medium business (SME) growth in the Midlands.
- Total investments
- 16
- Lead investments
- 7
- Investments · 12mo
- 0
- Active investors
- 0
Sector focus
- Finance
- Financial Services
Investment portfolio
- ImmuONE
Participated · Equity · Mar 2025
ImmuONE develops a 3D human lung model that enables companies to replace or reduce the need for animal testing. Its platform supports respiratory safety tests and more complex immunology assays that show long-term effects of substances on the lung, including potential to cause inflammation. The company serves consumer products and pharmaceutical customers and has recently taken on clients in the chemicals sector. ImmuONE plans to use the newly raised funds to develop its capabilities, target new sectors such as agrichemicals and automotive, and expand its team. It intends to hire two new scientists as part of that expansion. The company raised £600K in this round to support those developments. ImmunONE has developed a laboratory-grown 3D human lower lung tissue and immune-cell model that assesses the safety of drugs, chemicals and cosmetics without using animals. The model enables testing of small airways and lung inflammation, producing results that are more reliable and reproducible than animal tests or invasive lung‑scraping. The technology was developed by Dr Abigail Martin during her PhD and the company was founded with Professor Victoria Hutter in 2019. ImmunONE serves around 20 customers globally, including blue‑chip chemical and consumer‑products companies, and has generated over £1m in revenue since its launch two years ago. The company plans to use the funds to move into new headquarters in Milton Keynes, open new laboratories in Stevenage to expand capacity, continue R&D, grow the team and create six new jobs. ImmunONE is based in Hatfield, UK.
- OneUp Sales
Participated · Equity · Feb 2025
OneUp is a Tamworth, UK-based platform that uses gaming technology to manage and motivate sales teams. The platform enables managers to track data and gain insights to improve performance, incentivise sales teams and celebrate success. The company is led by CEO Derry Holt and employs 40 people, and has been achieving year-on-year growth. OneUp has annual recurring revenue (ARR) of £2.7m and serves over 350 customers, including Hitachi Vantara, Xcede and Premier Group. It intends to use the new funds to build its US customer base, where it already has a strong presence, and to further develop its product. OneUp Sales is a Staffordshire, UK-based sales performance management platform founded in 2016 by former games developers Derry Holt and James Heath. The product helps businesses manage and motivate salespeople by enhancing reporting, improving accountability, creating friendly competition, and celebrating wins. It integrates with almost 30 different CRM systems and is used by over 250 companies in the UK, including Recruitment Entrepreneur, Xcede, Investigo, and Premier Group. The company currently employs 36 staff. OneUp plans to use the new funding to enhance its existing product, launch a commission management solution later this year to simplify calculating and managing sales commission, and to create a number of new jobs in the year ahead. The latest investment follows two earlier funding rounds from Mercia and MEIF totalling £750,000. Stormburst Studios is a Birmingham, UK-based startup co-founded by Derry Holt and James Heath that develops game‑inspired software for business use. Its core product, OneUp, lets sales teams compete in a fantasy-sports style competition, using leaderboards and dashboards to replace spreadsheets. OneUp is designed to motivate and engage employees while giving managers detailed performance insights. The company raised seed funding to continue product development and expand commercial efforts. Planned uses for the capital include further development of the OneUp platform, key hires in marketing and business development, and building relationships with clients across recruitment, insurance and telesales sectors.
- Get Well Soon
Participated · Equity · Dec 2024
Get Well Soon is a UK healthcare startup that helps patients access medical specialists and self-pay healthcare. The company operates a platform that links self-pay patients with private hospitals, clinics and surgeons. Its service offering spans orthopedics, general surgery, urology and diagnostic procedures, and it currently has 50 surgeons onboard. The platform attracts over 3,000 visitors a month. Get Well Soon is part of the Medmin Group, a West Midlands medical business that supports surgeons and helps more than 2,500 patients each year. The company raised £400K and intends to use the funds to further expand its patient-to-provider platform.
- Zedify
Participated · Equity · Jul 2024
Zedify is a sustainable cargo bike delivery company based in Cambridge that operates a cargo bike delivery network across the UK. It currently works in Brighton, Bristol, Cambridge, London, Manchester, Norwich, Plymouth, Edinburgh and Glasgow. The company plans to expand into more cities and aims to operate in 51 UK towns and cities within the next five years, including launching a new Midlands hub later this year. Zedify intends to use new funding to enhance its technology and expand its teams of riders, sales and customer care staff. Led by CEO Rob King, the company expects to create 80 new jobs, including 20 roles in the new Midlands hub. Zedify expects to triple its turnover in the year ahead. Zedify operates a network of microhubs on the edge of city centres where parcels are consolidated for onward delivery, supported by its own fleet of electric cargo bikes. It runs a technology platform that offers consumers delivery time choices and optimises for cost‑effective, low‑impact routes. The company partners with national delivery firms, major retail brands and hundreds of regional and local businesses. Zedify raised £5M in funding to accelerate expansion. The funds will be used to roll the service out to more locations including Birmingham and Manchester and to more than double in size. The company plans to create over 120 jobs nationwide (including 20 in the Midlands) and to move its headquarters to Birmingham. Zedify operates a smart, consolidated zero-emission delivery system that combines electric trikes, cargo bikes and local depots to serve urban first- and last-mile needs. The company offers a franchise model intended to enable rapid national growth while reducing congestion, air pollution and carbon emissions. Zedify has developed a technology platform to optimise depot operations and delivery routing as volumes scale. The business plans to expand its national network from 8 depots to as many as 20 by 2022 and will hire across sales, marketing and operations to support that growth. Co-founders Rob King and Sam Keam founded Zedify in 2018 and bring over 20 years of combined experience in zero-emission logistics. Zedify is also a registered Real Living Wage employer and emphasizes community and city benefits alongside commercial traction.
- Ostique
Led · Equity · Apr 2024
Ostique is a health-tech company focused on re-imagining ostomy care through a dual offering: a patented, feature-rich ostomy bag and a digital community platform called “Ostique Connect.” The bag incorporates noise reduction, improved adhesion and odour control, directly tackling common pain points for ostomates. Ostique Connect will provide peer support, tailored advice and mental-health resources, creating a holistic care ecosystem that extends beyond the physical product. The firm recently secured £457,000 from the Midlands Engine Investment Fund (MEIF) to accelerate product launch and platform development. This capital will help bring the ostomy bag to market faster while expanding the online community. The company positions itself to disrupt a niche yet essential medical-device segment with patient-centred innovation and integrated digital support.
Team
No current team members are available.